Scintigraphic prediction of response to chemotherapy in patients with breast cancer: Technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography.

International journal of oncology

Volumn 20, Issue 1, 2002, Pages 53-58

  Takeuchi, Naoko ^a   Fukumoto, Mitsutaka ^a   Nishioka, Akihito ^a   Akagi, Naoki ^a   Murata, Yoriko ^a   Takeuchi, Seisho ^a   Ogawa, Yasuhiro ^a   Yoshida, Shoji ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DIAGNOSTIC AGENT; DOXORUBICIN; DRUG DERIVATIVE; ORGANOPHOSPHORUS COMPOUND; PIRARUBICIN; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE; THALLIUM;

ADULT; AGED; ARTICLE; BREAST TUMOR; FEMALE; HUMAN; MIDDLE AGED; PAGET NIPPLE DISEASE; PROGNOSIS; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PROGNOSIS; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

MLCS; MLOWN;

EID: 0036133894     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.20.1.53     Document Type: Article

References (0)